The CDC will decide on using the Covid-19 booster shots for different vaccines by late October
... [+]
answers is seen during a Senate Appropriations Subcommittee hearing to examine the FY 2022 budget request for the Centers for Disease Control and Prevention on May 19, 2021 in Washington, DC.
Currently the CDC recommends that people receive a booster shot from the same manufacturer as their initial Covid-19 vaccine. Pfizer-BioNTech is the only manufacturer that has received approval from the U.S. Food and Drug Administration to distribute booster shots to people over the age of 65, high-risk workers and those who are immunocompromised, six months after receiving initial doses of the Pfizer vaccine.Dr. Anthony Fauci, the nation’s leading infectious disease expert, told McClatchy last week that the ability tovaccines and booster shot manufacturers could allow more people to access the boosters.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Covid-19: Girl's Covid death, and Scotland's passport 'teething problems'Five things you need to know about the coronavirus pandemic this Sunday.
Baca lebih lajut »
CDC to pregnant women: Get vaccinated against Covid-19The CDC issued an urgent recommendation Wednesday for pregnant women and those who have recently given birth to get vaccinated against coronavirus.
Baca lebih lajut »
California To Require All Schoolchildren To Get COVID-19 ShotsCalifornia has announced the nation's first coronavirus vaccine mandate for schoolchildren.
Baca lebih lajut »
Will You Need A Booster Vaccine Against Covid-19?Infectious disease expert Dr. Mark Kortepeter discusses what we know so far about Covid-19 vaccine booster shots and what information scientists need to make the decision.
Baca lebih lajut »
U.S. COVID-19 Cases Drop for First Time in 3 MonthsThe fourth wave of the COVID-19 pandemic in the U.S. may be tapering off as cases drop for the first time in 3 months, according to the latest update from the University of Minnesota’s Center for Infectious Disease Research and Policy.
Baca lebih lajut »